Acute myelomonocytic leukemia (AMML) is a subtype of acute myeloid leukemia characterized by the proliferation of myeloblasts and monoblasts in the bone marrow and peripheral blood. This condition is clinically significant as it often presents with severe symptoms and requires immediate medical intervention. The ICD-10 Code C92.50 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this serious hematological disorder.
ICD-10 Code C92.50 specifically denotes acute myelomonocytic leukemia that has not achieved remission. This condition involves the accumulation of immature myeloid and monocytic cells, leading to significant hematological abnormalities. The code is utilized in clinical documentation and billing when a patient is diagnosed with AMML and has not responded to initial treatment, indicating the need for ongoing management and intervention.
Acute myelomonocytic leukemia, not having achieved remission, is a severe hematological malignancy that arises from the uncontrolled proliferation of myeloid and monocytic cells. The condition can progress rapidly, leading to life-threatening complications, necessitating urgent medical attention and intervention.
In clinical workflows, ICD-10 Code C92.50 is essential for documenting the diagnosis of acute myelomonocytic leukemia that has not achieved remission. It plays a critical role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code C92.50 links subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of acute myelomonocytic leukemia. This connection is vital for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
Acute myelomonocytic leukemia, not having achieved remission, requires immediate and aggressive treatment strategies to manage the disease effectively.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C92.50 is crucial in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85025 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 38221 | Bone marrow aspiration and/or biopsy. |
Common Questions About Using ICD-10 Code C92.50 for Acute myelomonocytic leukemia, not having achieved remission
What are the common symptoms of acute myelomonocytic leukemia?
Common symptoms include fatigue, fever, easy bruising or bleeding, and recurrent infections. Patients may also experience weight loss and night sweats due to the disease's impact on bone marrow function.
How is acute myelomonocytic leukemia treated?
Treatment typically involves chemotherapy to induce remission, along with supportive care such as blood transfusions and antibiotics to manage infections. Treatment plans may vary based on individual patient factors.
When should ICD-10 Code C92.50 be used?
ICD-10 Code C92.50 should be used when a patient is diagnosed with acute myelomonocytic leukemia that has not achieved remission, indicating the need for ongoing treatment and management.
What is the prognosis for patients with acute myelomonocytic leukemia?
The prognosis for patients with acute myelomonocytic leukemia can vary significantly based on factors such as age, overall health, and response to treatment. Early diagnosis and aggressive treatment are crucial for improving outcomes.
Clinical Notes
SOAP notes
DAP notes
AI medical notes